SPOTLIGHT: Cash still scarce for Florida's biotech start-ups

Florida's biotech start-ups do a good job of attracting venture capital investment. But most of that money came from out-of-state investors, and Florida-based VCs are a long way from being able to support their state's growing biotech sector. Report

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.